Multivariate logistic regression analysis for increased ESMCSA or ESMCT from baseline to 12 months after LDLLT
| Variable | Increased ESMCSA at 12 months (ratio to baseline >1) | Increased ESMCT at 12 months (ratio to baseline >1) | ||||
| Odds ratio | 95% CI | p-value | Odds ratio | 95% CI | p-value | |
| BMI kg·m−2 | 0.88 | 0.61–1.25 | 0.48 | – | – | – |
| ESMCT HU | 1.20 | 1.06–1.248 | 0.001 | 1.00 | 0.83–1.01 | 0.92 |
| Tacrolimus use n | 0.23 | 0.03–1.53 | 0.13 | – | – | – |
| Tracheostomy n | – | – | – | 0.40 | 0.032–4.05 | 0.44 |
| Δ at 3 months of ESMCSA, cm2 (3 months – baseline) | 2.54 | 1.31–7.22 | 0.002 | – | – | – |
| Δ at 3 months of ΔESMCT, HU (3 months – baseline) | – | – | – | 1.60 | 1.17–2.62 | 0.001 |
| R2 | 0.54 | 0.46 | ||||
Increased ESMCSA and increased ESMCT at 3 months were calculated by subtracting the values at baseline from those at 3 months. ESMCSA: cross-sectional area of the erector spinae muscles; ESMCT: mean computed tomography values of the erector spinae muscles; LDLLT: living-donor lobar lung transplantation; BMI: body mass index; CI: confidence interval; R2: coefficient of determination.